Yet, during closing arguments, the prosecutor told the jury: "Perhaps if Mr. Schmidkunz had been a better Christian, this murder would not have happened."
On top of everything else, his father said, the family was crushed by this comment.
But the worst anguish was yet to come. The jury deliberated less than 4 hours before returning a guilty verdict.
Mr Schmidkunz describes that moment by saying, "a stake driven through my heart would have hurt less than hearing the words: "We the jury find Zachary Schmidkunz guilty".
But the nightmare did not end there for Gail and Rhonda Schmidkunz, in fact, it must seem like their Zoloft nightmare will never end.
In December 2005, Alexis' mother, Lisa Anderson filed a wrongful death lawsuit against Pfizer and Zach's parents, alleging that his parents should have known about his depression and suicidal thoughts and kept him away from a gun and that Pfizer knew of, but failed to warn that Zoloft's side effects could lead to uncontrollable rage in young patients.
Bryant Haskins, a spokesman for Pfizer, said in a statement that Zoloft has been on the market for 14 years and has been used safely by millions. "There is no scientifically based evidence to suggest that Zoloft causes patients who are being treated to commit violent acts harming other people," Haskins said.
That statement does not jive with the warning below issued in a Dear Doctor letter to physicians in Canada on May 26, 2004, which states in part:
Health Canada Endorsed Important Safety Information on ZOLOFT
Adult and Pediatrics: Additional data
"There are clinical trial and post-marketing reports with SSRIs and other newer antidepressants, in both pediatrics and adults, of severe agitation-type adverse events coupled with self-harm or harm to others. The agitation-type events include: akathisia, agitation, disinhibition, emotional lability, hostility, aggression, depersonalization. In some cases, the events occurred within several weeks of starting treatment.
"Rigorous clinical monitoring for suicidal ideation or other indicators of potential for suicidal behavior is advised in patients of all ages. This includes monitoring for agitation-type emotional and behavioural changes."
For more information go to Lawyers and Settlements.com
http://www.lawyersandsettlements.com/articles/pfizer_gsk.html
Evelyn Pringle
evelyn.pringle@sbcglobal.net
On top of everything else, his father said, the family was crushed by this comment.
But the worst anguish was yet to come. The jury deliberated less than 4 hours before returning a guilty verdict.
Mr Schmidkunz describes that moment by saying, "a stake driven through my heart would have hurt less than hearing the words: "We the jury find Zachary Schmidkunz guilty".
In December 2005, Alexis' mother, Lisa Anderson filed a wrongful death lawsuit against Pfizer and Zach's parents, alleging that his parents should have known about his depression and suicidal thoughts and kept him away from a gun and that Pfizer knew of, but failed to warn that Zoloft's side effects could lead to uncontrollable rage in young patients.
Bryant Haskins, a spokesman for Pfizer, said in a statement that Zoloft has been on the market for 14 years and has been used safely by millions. "There is no scientifically based evidence to suggest that Zoloft causes patients who are being treated to commit violent acts harming other people," Haskins said.
That statement does not jive with the warning below issued in a Dear Doctor letter to physicians in Canada on May 26, 2004, which states in part:
Health Canada Endorsed Important Safety Information on ZOLOFT
Adult and Pediatrics: Additional data
"There are clinical trial and post-marketing reports with SSRIs and other newer antidepressants, in both pediatrics and adults, of severe agitation-type adverse events coupled with self-harm or harm to others. The agitation-type events include: akathisia, agitation, disinhibition, emotional lability, hostility, aggression, depersonalization. In some cases, the events occurred within several weeks of starting treatment.
"Rigorous clinical monitoring for suicidal ideation or other indicators of potential for suicidal behavior is advised in patients of all ages. This includes monitoring for agitation-type emotional and behavioural changes."
For more information go to Lawyers and Settlements.com
http://www.lawyersandsettlements.com/articles/pfizer_gsk.html
Evelyn Pringle
evelyn.pringle@sbcglobal.net
Next Page 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).
